/ Sep 30, 2026
/ Sep 30, 2026

FG discovers major Lithium and Platinum deposits in Kaduna

Published on

By

Nigeria has announced the discovery of what officials describe as a world-class mineral province in Kaduna State, containing significant deposits of lithium, platinum group metals, gold, nickel, copper and rare earth elements.

 

Speaking at the African Natural Resources and Energy Investment Summit 2026 in Abuja, Nigeria’s Minister of Solid Minerals Development, Dele Alake, said the discovery represents one of the most important developments in the country’s mining sector in recent years.

According to TheCable, the mineral deposits were verified by the Nigerian Geological Survey Agency following exploration activities conducted by a private company in collaboration with the agency.

Alake said the newly identified polymetallic province contains exceptionally high-grade deposits of strategic minerals that are increasingly in demand for clean energy technologies, battery production and advanced manufacturing.

“This is the first time I am announcing this publicly,” the minister said, describing the Kaduna find as a significant boost to Nigeria’s ambitions of becoming a major destination for critical mineral investments.

The announcement came shortly after Steron Mining and Company Limited unveiled an estimated 3.3 million metric tonnes of lithium reserves at its Abuja mining site during a facility tour for summit delegates.

Alake said the discovery strengthens Nigeria’s position in the global competition for critical minerals and supports the government’s drive to attract sustainable mining investments.

He also reiterated the Federal Government’s plan to move away from exporting raw minerals and instead focus on local processing and value addition.

“For too long, Nigeria’s mineral endowment did not translate into sufficient national value,” the minister said, noting that investors have already committed billions of dollars to mineral processing projects aimed at transforming the economy.

Speaking on the lithium reserves, Abu Omar, chief executive officer of Steron Mining, said the company originally operated as a granite quarry before discovering lithium deposits and later identifying occurrences of tantalite.

Omar said exploration work remains ongoing and that early findings continue to show promising prospects.

The discovery comes as global demand for lithium, rare earth elements and other critical minerals continues to rise, driven by the expansion of electric vehicles, renewable energy technologies and advanced industrial manufacturing.

You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Must Read

Japanese surgeons perform the world’s first heart muscle stem cell surgery using iPS-derived cells

Japan performs world’s first heart muscle stem cell surgery

A hospital in Japan has performed the world’s first surgery using commercially available sheets of heart muscle cells derived from induced pluripotent stem cells, marking a significant step in regenerative heart treatment.   The procedure was carried out on Tuesday at Osaka Keisatsu Hospital on a woman in her 50s. The hour-long operation involved transplanting sheets of heart muscle cells into her heart. The treatment received conditional government approval in Japan in March, allowing its first clinical use. “Our hope is that this will improve the patient’s quality of life,” surgeon Yoshiki Sawa, head of Osaka Keisatsu Hospital, told reporters after the operation. The regenerative therapy was previously tested on eight patients with ischaemic heart disease, a condition in which narrowed heart arteries reduce blood flow to the heart. According to Japanese media reports, all eight patients experienced an easing of symptoms, while four recorded improvements in heart function. Sawa developed the technology in collaboration with Japanese scientist Shinya Yamanaka, who won the 2012 Nobel Prize in Physiology or Medicine for his research into induced pluripotent stem cells, commonly known as iPS cells. iPS cells are created by reprogramming mature specialised cells into a more flexible, juvenile-like state, allowing them to develop into different types of cells. The therapy is primarily intended for heart patients who have exhausted other treatment options. It is expected to help improve heart muscle function, heart failure symptoms, cardiac performance and exercise tolerance. Sawa’s team plans to carry out similar procedures on 75 patients by 2033 as part of efforts to establish the treatment’s effectiveness and safety. The treatment could receive full authorisation if its benefits and safety are demonstrated during the seven-year evaluation period, according to Japanese media reports. Japan also granted conditional approval in March for an iPS cell-based treatment for Parkinson’s disease following a successful clinical trial.
Read more

Editor's Pick

Trending News

Newsletter

Enter your email address and receive notifications of news by email.

You have been successfully Subscribed! Ops! Something went wrong, please try again.

© 2026 GongNews. All Rights Reserved.